Piqray 200 mg / 50 mg – DIN 02497085
Piqray is Alpelisib 200 mg / 50 mg (tablet), sold in Canada. It is used for breast cancer and male breast neoplasms. It is supplied by Novartis Pharmaceuticals Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Alpelisib 200 mg / 50 mg
- Brand
- Piqray
- Strength
- Alpelisib 200 mg / Alpelisib 50 mg
- Used for
- Breast cancer and male breast neoplasms
- Form
- Tablet
- Manufacturer
- Novartis Pharmaceuticals Canada Inc
- Sold in
- Canada
- DIN
- 02497085
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Alpelisib used for?
Alpelisib is used for breast cancer and male breast neoplasms.
Official uses from the US prescribing label
PIQRAY is indicated in combination with fulvestrant for the treatment of adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen.
From the FDA-approved label on DailyMed (published Dec 16, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02497085.
- It names Piqray, Alpelisib 200 mg / 50 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Piqray kit contains 50 mg and 200 mg piqray tablets by Novartis Pharmaceuticals Canada Inc.
In Canada: prescription only.
Ingredients
Active: Alpelisib, Alpelisib
Other Alpelisib pills
- Y7 NVR Alpelisib 125 mg Yellow, oval, 13 mm Used for breast cancer and male breast neoplasms
- UL7 NVR Alpelisib 150 mg Red, oval, 14 mm Used for breast cancer and male breast neoplasms
- UL7 NVR Alpelisib 150 mg Red, oval Used for breast cancer and male breast neoplasms
- CL7 NVR Alpelisib 200 mg Yellow, oval, 16 mm Used for breast cancer and male breast neoplasms
- YL7 NVR Alpelisib 200 mg Red, oval, 16 mm Used for breast cancer and male breast neoplasms
- YL7 NVR Alpelisib 200 mg Red, oval Used for breast cancer and male breast neoplasms
- C7 NVR Alpelisib 50 mg Yellow, round, 7 mm Used for breast cancer and male breast neoplasms
- L7 NVR Alpelisib 50 mg Pink, round, 7 mm Used for breast cancer and male breast neoplasms